Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer (Q37123465)
Jump to navigation
Jump to search
scientific article published on 17 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer |
scientific article published on 17 February 2009 |
Statements
Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer (English)
R Sharma
J Graham
H Mitchell
A Brooks
17 February 2009
1 reference
1 reference
1 reference
1 reference